The FDA has approved a first-generation artificial pancreas system from Medtronic (Minneapolis), the company reported on Friday. The MiniMed 530G with Enlite artificial pancreas system with Threshold Suspend automation is designed for people with diabetes. Medtronic noted that the system is the first in the U.S. that can automatically stop insulin delivery when sensor glucose values reach a preset level and when the patient doesn`t respond to the Threshold Suspend alarm.